MedTek21 and AccessDX Laboratory have announced the immediate availability of a Covid-19 testing and compliance solution within New York State impacted by Executive Order No. 202.30.

The new solution for nursing homes and adult care facilities entities will enable bi-weekly infection testing and compliance tracking for all personnel, including employees, contract staff, medical staff, operators and administrators.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

This is in addition to the existing Covid-19 infection and laboratory antibody testing services for residents provided by the companies.

Enacted on 10 May, New York State Executive Order No. 202.30 requires that the operators and administrators of all nursing homes and adult care facilities must make arrangements for all personnel to be tested for Covid-19 twice a week.

Fines and penalties have been established for non-compliance with the executive order, ensuring adherence is an immediate priority for facilities across New York State.

MedTek21 and AccessDX said that their rapid-response teams will ensure facility operators have prompt and continuous access to test kits, results and reporting.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The full test status and chain-of-custody reporting are provided by the MedTek21 software, and the sample results will be available within 24-48 hours of receipt.

AccessDX Laboratory is operating under the emergency use authorisation (EUA) as filed with the US Food and Drug Administration (FDA). It is CLIA-certified, CAP-accredited and certified in New York State.

MedTek21 and AccessDX launched their Covid-19 testing and support operations in March. They currently support testing initiatives at more than 600 clinical and employer groups in the country.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact